Anterix (ATEX) Cost of Revenue (2013 - 2021)

Anterix's Cost of Revenue history runs 9 years deep, the most recent figure standing at $5000.0 for Q4 2021.

• Quarterly Cost of Revenue fell 99.08% year-over-year to $5000.0 in Q4 2021, while the trailing twelve-month figure through Mar 2023 was $5000.0 (down 99.09% YoY) and the FY2022 annual result came in at $5000.0, down 99.69% from the prior year.
• Cost of Revenue was $5000.0 for Q4 2021 at Anterix, down from $543000.0 in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.3 million in Q1 2018 and bottomed at $5000.0 in Q4 2021.
• A 5-year average of $1.2 million and a median of $974000.0 in 2018 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2018 — Cost of Revenue grew 26.24% — and 2021, when it tumbled 99.08%.
• Anterix's Cost of Revenue stood at $2.0 million in 2017, then slumped by 51.69% to $974000.0 in 2018, then tumbled by 35.22% to $631000.0 in 2019, then decreased by 13.95% to $543000.0 in 2020, then tumbled by 99.08% to $5000.0 in 2021.
• Business Quant data shows ATEX's Cost of Revenue at $5000.0 in Q4 2021, $543000.0 in Q4 2020, and $515000.0 in Q3 2020.